The pandemic provided a reason to the stock market to be excited about the pharma sector that had been facing lacklustre prospects amid challenges in the US business, USFDA compliance issues, pricing pressure, big-bang acquisitions not working out on expected lines and modest growth in the domestic market.
A $73 billion short book is putting pressure on rupee
The Indian rupee is underperforming among emerging Asian currencies due to the Reserve Bank of India’s (RBI) strategy to bolster its foreign-exchange reserves. The RBI’s
June 2, 2025